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Abstract
Purpose Submucosal invasion depth (SID) in colorectal car-
cinoma (CRC) is an important factor in estimating risk of
lymph node metastasis, but can be difficult to measure, lead-
ing to inadequate or over-extensive treatment. Here, we aimed
to clarify the practical aspects of measuring SID in T1 CRC.
Methods We investigated 568 T1 CRCs that were resected
surgically at our hospital from April 2001 to December
2013, and relationships between SID and clinicopathological
factors, including the means of measurement, lesion morphol-
ogy, and lymph node metastasis.
Results Of these 568 lesions, the SID was ≥1000 μm in 508
lesions. SIDs for lesions measured from the surface layer were
all ≥1000 μm. Although lesions with SIDs ≥1000 μm were
associated with significantly higher levels of unfavorable his-
tologic types and lymphovascular infiltration than shallower
lesions, a depth of ≥1000 μm was not a significant risk factor
for lymph node metastasis (LNM) (6.7 vs. 9.8 %; P=0.64),
and no lesions for which the sole pathological factor was SID
≥1000 μm had lymph node metastasis. Protruded lesions
showed deeper SIDs than other types.
Conclusions Althoughwe found several problems ofmeasuring
SID in this study, we also found, surprisingly, that SID is not a
risk factor for lymph node metastasis, and its measurement is not
needed to estimate the risk of lymph node metastasis.
Keywords Risk factor . T1 colorectal carcinoma . Lymph
nodemetastasis . Invasion depth
Introduction
In T1 colorectal cancer (CRC), deep submucosal invasion
thought to signify malignant potential and submucosal invasion
depth (SID) are considered important predictors of risk of lymph
node metastasis (LNM) [1–9]. Haggitt’s classification criteria
defined level 2 as a risk of LNM [10–12]. Kudo’s Classification
of Degree of Submucosal Invasion defined sm1c, sm2, and sm3
as risk factors for LNM [13, 14]. Although the European Society
for Medical Oncology (ESMO) guidelines recommend surgical
resection after endoscopic resection if deeper infiltration into the
submucosa is found [15], deeper infiltration into the submucosa
is not well defined in these guidelines. Kitajima et al. established
themethod for measuring SID and reported no LNMwere found
in lesions with SID <1000 μm [5]. Therefore, SID has been
thought to be an important factor in estimating LNM risk. The
clinical guidelines of the Japanese Society for Cancer of the
Colon and Rectum (JSCCR) describe the method of measuring
an SID and advise additional surgical colectomy with lymph
node dissection after endoscopic treatment for lesions with SID
≥1000 μm [16]. This B1000-μm rule^ is also recommended as a
criterion for additional colectomy in many previous papers [8,
17, 18] and is used as a gold-standard indicator for endoscopic
diagnoses, such as magnifying endoscopy or image-enhanced
endoscopy [19–23].
Overuse of surgery has been recently addressed as a major
problem in T1 CRCs [24, 25]. As the percentage of T1 CRCs
that lead to LNM is estimated as 6.3–17% [1–7, 26, 27], many
patients who undergo additional colectomies do not have
LNM and might not need further resection. Moreover, several
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studies report that among patients with SID ≥1000 μm but no
risk factors for LNMs (lymphovascular infiltration, unfavor-
able histological types, or tumor budding), few develop LNM
[5, 27–29]. As endoscopic techniques progress, endoscopic
treatment is becomingmore widely acceptable for lesions with
SID ≥1000 μm [17, 30, 31]. Problems in measuring SID are
also reported in some studies, and both measuring methods
and lesion morphology could affect measurement results [32,
33]. However, as these published cases and reports are few, we
performed this larger-scale study to clarify the practical issues
and significance of measuring SID in T1 CRCs.
Methods
Subjects
In the present study, we analyzed T1 CRCs that were resected at
Showa University Northern Yokohama Hospital in Japan from
April 2001 to December 2013. A total of 21,060 colorectal neo-
plasms, excluding advanced carcinomas, had been resected
endoscopically or surgically. Of these, 902 were T1 CRCs. To
evaluate precise pathological diagnoses and LNM outcomes, we
excluded lesions from 334 patients, including 279 patients who
underwent only endoscopic resection, 20 who had synchronous
advanced CRCs, one with familial adenomatous polyposis, three
with Lynch syndromes, one with inflammatory bowel disease,
and 30 whose specimens were impossible to evaluate patholog-
ically in detail because of damage or loss (Fig. 1). In total, 568
patients with T1 CRC were included in this study, of whom 295
underwent surgical resection and lymph node dissection as first-
line treatment, and 273 underwent first-line endoscopic resection
followed by additional surgery with lymph node dissection.
None of the patients received preoperative radiotherapy or neo-
adjuvant chemotherapy. We found each patient’s age, sex, and
tumor location from their hospital records. For themorphological
classification, we divided the lesions into three types: flat elevat-
ed type (0–IIa or laterally spreading tumor [LST]) [13]; protruded
type (0–Is, Isp, or Ip); and depressed type (0–IIc, IIc+IIa, IIa+IIc,
Is+IIc, or Ip+IIc); Fig. 2 [34, 35].
Histologic examination
All resected specimens were immediately fixed in 10 % buff-
ered formalin solution, observed with a focus on pit pattern
using a stereomicroscope, and dissected at the point where the
deepest invasion area could be exposed on the cut end surface.
The other histological specimens were subsequently dissected
into parallel 2- to 3-mm-thick sections and stained with hema-
toxylin and eosin (H&E). An experienced pathologist (S.H.)
examined all the specimens histologically. Histologic grade
was diagnosed based on the World Health Organization Clas-
sification of Tumors [36] and the current JSCCR guidelines.
Unfavorable histological types were poorly differentiated ad-
enocarcinoma (Por) or mucinous carcinoma (Muc) at any part
Excluded
902 T1 CRCs
21060 colorectal lesions 
Resected between April 2001 and December 2013 
568 T1 CRCs
279 Only endoscopic resection
20 Presence of synchronous advanced CRCs
1 familial adenomatous polyposis
3 Lynch syndromes
1 Inflammatory bowel disease
30 impossible to evaluate pathological findings
Fig. 1 Patient flow chart. CRC colorectal carcinoma
Fig. 2 Kudo’s morphological/
development classification
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of the lesion; favorable histological types were well or mod-
erately differentiated adenocarcinoma. Double staining with
H&E and Victoria blue (Muto Pure Chemicals Co., Ltd., To-
kyo, Japan) was used to diagnose vascular infiltration. Lym-
phatic infiltration and status of muscularis mucosae were
evaluated using H&E staining and immunostaining with D2-
40 antibody (Dako North America Inc., Carpinteria, CA,
USA) and desmin antibody (Dako North America Inc.), re-
spectively. Tumor budding was defined as a cancer cell nest
consisting of 1 or 5 cells that had infiltrated the interstitium at
the invasive margin of the cancer. After selecting the field
where budding was the most intensive, buddings were count-
ed in a 0.785-mm2 field as observed through an objective lens.
Depending on the number of buddings, budding grade was
scored as Grade 1: 0–4; Grade 2: 5–9; and Grade 3: ≥10 [8,
16, 37]. Grades 2–3 were defined as tumor budding positive.
We measured SID according to the clinical guidelines of
the JSCCR [5, 16]. SID can be measured in two ways (Fig. 3).
When it was possible to identify or estimate the location of the
muscularis mucosae, we measured the SID directly from the
line of the muscularis mucosae (method A; Fig. 3a). When the
line of the muscularis mucosae was not easily identified be-
cause of carcinoma invasion, we measured the SID from the
surface layer of the lesion (method B; Fig. 3b).
The lesions were divided into two groups: those with SID
<1000 μm and those with SID ≥1000 μm. Between the two
groups, we compared incidences of clinicopathological fac-
tors: age, sex, tumor location, tumor morphology, tumor size,
method of measurement, mean SID, histologic type, lymphat-
ic infiltration, vascular infiltration, tumor budding, and LNM.
Mean SID and the LNM rates were calculated for each mor-
phological type. We also assessed correlations between histo-
logic type, lymphatic infiltration, vascular infiltration, tumor
budding, and LNM, and SID by depth (0–999 μm, 1000–
1999 μm, 2000–2999 μm, 3000–3999 μm, 4000–4999 μm,
5000–5999 μm, 6000–6999 μm, 7000–7999 μm, and
≧8000 μm,). Finally, in lesions with SID ≥1000 μm, we ex-
amined correlations between LNM and histologic type, lym-
phatic infiltration, vascular infiltration, and tumor budding.
A
B
Fig. 3 Method used to measure submucosal invasion depth. a When
identifying or estimating location of the muscularis mucosae, the
submucosal invasion depth is measured directly from the line of the
muscularis mucosae. b When the muscularis mucosae have not been
identified, the submucosal invasion depth is measured from the lesion’s
surface layer
Table 1 Submucosal depth
(<1000 or ≥1000 μm)
and clinicopathological factors
<1000 μm (n=60) ≥1000 μm (n=508) P value
Age (years), mean (SD) 65.5±12.6 64.9±11.2 0.7099
Male sex 42 (70.0) 310 (61.0) 0.2062
Location (rectum) 9 (15.0) 158 (31.1) 0.0103
Morphology (depressed type) 8 (13.3) 159 (31.3) 0.0040
Tumor size (mm), mean (SD) 19.5±11.9 20.7±11.3 0.4325
Method of measurement (A) 60 (100) 123 (24.2) <0.001
SID (μm), mean (SD) 406±302 3680±2233 <0.001
Histologic type (por or muc) 5 (8.3) 101 (19.9) 0.0341
Lymphatic infiltration (+) 17 (28.3) 220 (43.3) 0.0271
Vascular infiltration (+) 6 (10.0) 183 (36.0) <0.001
Budding (+) 12 (20.0) 146 (28.7) 0.1722
Lymph node metastasis (+) 4 (6.7) 50 (9.8) 0.6401
Data are expressed as the number of patients (%) unless otherwise indicated
Por or muc poorly differentiated adenocarcinoma or mucinous carcinoma, SD standard deviation, SID submu-
cosal invasion depth, Budding tumor budding
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Statistical analysis
Data are presented as the mean±standard deviation. Differ-
ences were analyzed using the χ2 test, Fisher’s exact test,
Student’s t test, or Ryan multiple comparison as necessary.
Statistical significance was defined as a P<0.05. All statistical
analyses were performed using R version 2.10.0. (http://www.
r-project.org).
The ethics committee of our hospital approved the study
protocol (approval number; 1408–01). Informed consent was
obtained from all patients before endoscopy or surgery. This
study was registered in the University Hospital Medical Net-
work Clinical Trials Registry (UMIN R000017608). A sum-
mary of this study was presented at the United European Gas-




Initial or additional surgery with nodal dissection was per-
formed for the 568 patients, who included 352 (62.0 %) men
and 216 (38.0 %) women with a mean age of 65.0±11.3 years
(range 31–93 years). Mean tumor size was 20.6±11.4 mm
(range 4–100 mm). Tumors included 151 flat elevated type,
250 protruded type and 167 depressed type lesions, with 401
lesions located in colon and 167 in rectum, and 54 (9.4 %)
lesions associated with LNM. Unfavorable histologic types
were seen in 106 (18.7 %) lesions, lymphatic infiltration was
positive in 237 (41.7 %) lesions, vascular infiltration was pos-
itive in 189 (33.5 %) lesions, and tumor budding was positive
in 158 (27.8 %) lesions.
We found 60 lesions (10.6 %) with SID <1000 μm and 508
(89.4 %) with SID ≥1000 μm. SID was measured from the
muscularis mucosa in 168 (32.2 %) lesions (method A) and
from the surface in 385 (67.8 %) lesions (method B). Among
the lesions measured using method A, 60 had SIDs <1000 μm
and 123 had SIDs ≥1000 μm. All lesions measured using
method B invaded deeper than 1000 μm.
SID and clinicopathological factors
The SID <1000 μm group had a lower rate of rectal T1 carci-
nomas than did the SID ≥1000μmgroup (15.0 vs. 31.1%;P=
0.010), depressed type lesions (13.3 vs. 31.3 %; P=0.004),
unfavorable histological types (8.3 vs. 19.9 %; P=0.034),
lymphatic infiltration (28.3 vs. 43.3 %; P=0.027), and vascu-
lar infiltration (10.0 vs. 36.0 %; P<0.001; Table 1). The two
groups did not significantly differ by age, sex, or tumor size.
The two groups also did not significantly differ by rate of
LNM (6.7 vs. 9.8 %; P=0.64) or tumor budding (20.0 vs.
28.7 %; P=0.17).
Figure 4 shows a lesion that metastasized to a lymph node
even though its SIDwas <1000 μm. It was found in a 50-year-
old male patient as a sessile lesion, 7 mm in diameter, in the
sigmoid colon. Its SID was 800 μm, with positive lymphatic
infiltration, and negative vascular infiltration and budding.
This patient was treated with an additional surgical colectomy.
SID and morphology
Mean SIDs of flat elevated type lesions, protruded type
lesions, and depressed type lesions were 2393±
A
B
Fig. 4 A case of lymph node metastasis with the submucosal invasion
depth <1000 μm. a A 7-mm sessile lesion was detected in the sigmoid
colon. b The submucosal invasion depth was 800 μm (the arrow)
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1652 μm, 4089±2796 μm, and 2974±1503 μm, respec-
tively (Table 2). The mean SID of protruded lesions
was greater than that of other types (P<0.01). Rates
of LNM for flat elevated (7.3 %), protruded (11.2 %),
and depressed (9.0 %) lesions did not significantly dif-
fer (P=0.42).
Table 2 Mean depth of invasion and incidences of lymph node metastasis by morphology of the lesion
Morphology Flat (n = 151) Protruded (n = 250) Depressed (n = 167) 
SID ( m) 2393 ± 1652 4090 ± 2796 2974 ± 1503 
* *
Number of LNM 11 (7.3%) 28 (11.2%) 15 (9.0%) 
LNM lymph node metastasis, SID submucosal invasion depth
*P<0.05
Table 3 Actual measured depth of submucosal invasion and pathological factors SX
SID (µm) n Por/muc Ly V Budding LNM 
0−999 60 5 (8.3) 17 (28.3) 6 (10.0) 12 (20.0) 4 (6.7) 
1000−1999 94 12 (12.8) 36 (38.3) * 27 (28.7) 22 (23.4) 6 (6.4) 
2000−2999 130 21 (16.2) 58 (44.6) 46 (35.4) 51 (39.2) 8 (6.2) 
3000−3999 102 23 (22.6) 45 (44.1) 39 (38.2) * 23 (22.6) 8 (7.8) 
4000−4999 67 14 (20.9) 31 (46.3) * 25 (37.3) 22 (32.8) 7 (10.5) 
5000−5999 50 11 (22.0) 21 (42.0) 17 (34.0) 16 (32.0) * 8 (16.0) 
6000−6999 32 9 (28.1) 19 (59.4) 18 (56.3) 9 (28.1) 8 (25.0) 
7000−7999 11 4 (36.4) 4 (36.4) 4 (36.4) 0 (0.0) 2 (18.2) 
8000- 22 7 (31.8) 6 (27.3) 7 (31.8) 3 (13.6) 3 (13.6) 
Data are expressed as the number of patients (%)
SID submucosal invasion depth, n number of lesions, Por/muc poorly differentiated adenocarcinoma ormucinous carcinoma, Ly lymphatic infiltration,V
vascular infiltration, Budding tumor budding, LNM lymph node metastasis
*P<0.05
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Actual measured SID value and pathological factors
Data on rates of unfavorable histologic type, lymphatic
infiltration, vascular infiltration, tumor budding, and
LNM according to SID are shown in Table 3. Rates
of unfavorable histologic type, lymphatic infiltration,
or budding did not significantly differ by SID. The rate
of vascular infiltration was significantly less in lesions
with a SID 0–999 μm than in lesions with a SID of
3000–3999 (P=0.0002), 4000–4999 (P=0.0008), and
6000–6999 μm (P<0.0001). The rate of LNM was
higher in lesions with a SID of 6000–6999 μm than
in lesions with a SID of 2000–2999 (P=0.0011).
Pathological factors and LNM in the SID ≥1000 μm group
Table 4 shows correlations between LNM and histologic type,
lymphatic infiltration, vascular infiltration, and tumor budding
in the SID ≥1000 μm group. No patients in this group devel-
oped LNM except those who had a pathological factor asso-
ciated with LNM (i.e., other than LNM). Among patients in
this group who had LNM-associated pathological factors, the
rate of LNM was 14.5 % (50/345).
Discussion
In the present study, we addressed some practical aspects of
measuring SID and clarified the significance of SID as a risk
factor for LNM.
First, the method of measuring SID affects the results. In the
present study, when measuring a SID from the surface layer
(method B), the depth was always ≥1000 μm. Therefore, if a
pathologist found that the muscularis mucosa of the lesion
could not be easily identified, the 1000 μm rule implies that a
colectomy with lymph node dissection should be considered
without measuring the SID. Yoshida et al. also reported that
SIDs measured from the surface layer were deeper than
1000 μm for all lesions [33]. Second, determining the baseline
is difficult in some lesions. The muscularis mucosae sometimes
show separations, and several baselines can be estimated in
some cases. Figure 5, for example, shows a 23-mm non-gran-
ular LST located in the ascending colon. As the muscularis
mucosae had split up, it was unclear which line we should
measure from. The SID was 630 μm when measured from
the lower line (Fig. 5a), 1325 μm when measured from the
upper line (Fig. 5b), and 2150 μm when measured from the
surface of the lesion (Fig. 5c). Whether additional surgical re-
section is necessary depends on which baseline the SID is mea-
sured from—in other words, the assessment of the pathologist
who diagnoses the lesion [38].
Third, SID is affected by lesion morphology [39]. SIDs are
greater for protruded lesions than for the other two types.
Reportedly, flat elevated type lesions, especially LSTs, grow
laterally, protruded types often grow upward, and depressed
type lesions tend to invade downwards [40]. These growing
Table 4 Correlation between lymph node metastasis and pathological
factors in lesions with submucosal depth of ≥1000 μm
Lymph node metastasis
+ −
Other pathological factorsa 50 295
None 0 163
aOther pathological factors include lymphovascular permeation, unfavor-
able histologic types (poorly differentiated adenocarcinoma, signet-ring





Fig. 5 A case in which determining the submucosal invasion depth
measurement baseline was difficult. a A 23-mm non-granular LST
located in the ascending colon. b The pathological finding of desmin
antibody staining. The submucosal invasion depth was 630 μm when
measured from the lower line (Fig. 5b, a), 1325 μm when measured
from the upper line (Fig. 5b, b), and 2150 μm when measured from the
surface of the lesion (Fig. 5b, c)
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patterns can affect SID measurements. Therefore, setting the
cutoff value at 1000 μm should consider morphology.
Fourth, some lesions develop depressed areas, and SID can
decrease during the lesion’s progression. Generally, lesions
with depressions or ulcerations are more advanced or aggres-
sive [41–46]. Figure 6 shows a lesion in which the center area
dimpled over a month’s time and the depth could have become
shallower (Fig. 6a, b). Although the SID was only 1400 μm in
the center of the lesion, the patient had an LNM. Increased
SID does not reflect the lesion’s malignancy or progression or
likelihood of LNM. Although the 1000-μm rule quantifies
SID as a comprehensible value and provides a clear-cut crite-
rion, its measurement can be difficult to perform and interpret.
SID does provide useful information. The presence of un-
favorable histological types or lymphovascular infiltration in
lesions with SID <1000 μm was significantly lower than in
those with SID ≥1000μm. Thus, the SID <1000 μm threshold
can help estimate the risk of unfavorable histological types or
lymphovascular infiltration. However, it is not a significant
risk factor for LNM. In the present study, four patients with
SID <1000 μm had LNM, two of whom had other LNM-
associated factors, such as unfavorable histologic type,
lymphovascular infiltration, or tumor budding. This concords
with other studies that report patients with SID <1000 μm
developing LNM [8, 24, 28, 47, 48]. Several studies have
reported deep SID as a risk factor for LNM in patients with
T1 CRC [1, 2, 4–9], and others did not evaluate LNM+ cases
with SID <1000 μm [5, 7, 9, 26], but most of these studies,
except for a meta-analysis, had fewer T1 CRC cases than in
the present study, even though our study was a single-center
study. In the Western World, the discrimination of the submu-
cosal layer into sm1, sm2 (<1000 μm), and sm3 (≥1000 μm)
is established to estimate the potential risk of lymph node
metastasis [49, 50]. But there also exists the redundancy in
the classification same as the B1000-μm rule.^
Moreover, of the cases with SID ≥1000 μm but no LNM-
associated pathological factors—unfavorable histological type,
lymphovascular infiltration, or tumor budding—none had
LNM. In contrast, among cases with SID ≥1000 μm and any
of these pathological factors, the rate of LNM was 14.5 %. If
the SID is omitted from the risk factors of LNM, we could
reduce the number of additional surgeries that are performed
according to the 1000-μm rule. Other studies have also report-
ed extremely low incidence of LNM regardless of SID among
lesions with no LNM-associated pathological factors [5, 24,
27–29]. Such lesions might be treated only with endoscopic
resections. Currently, other factors such as histological type,
lymphovascular infiltration, and tumor budding are considered
more important than a SID ≥1000 μm. In this study, we ad-
dressed several practical problems inmeasuring SID; therefore,
more detailed prospective investigations of LNM risk factors
will be needed besides SID. Hereafter, without causing incom-
plete endoscopic resections, more accurate criteria to recom-
mend additional surgery should be established.
A B
C
Fig. 6 A typical case in which
the submucosal invasion depth
might become shorter during the
carcinoma’s progression. a A 19-
mm IIa+IIc lesionwas detected in
the rectosigmoid. b The
observation of the same lesion
1 month later. c The pathological
finding with hematoxylin and
eosin staining of the lesion. The
submucosal invasion depth was
1400 μm in the center of the
lesion (the arrow)
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Our study is limited by being a single-center retrospective
study, which could reflect some selection bias. However, the
pathological specimens were examined in the same manner
[48], and with a larger sample size, than any other single-
institutional reports published so far. Second, patients treated
only by endoscopic resection were excluded from this analy-
sis, as such endoscopically removed lesions occasionally dis-
guise a metachronous recurrence in consideration of skip
lymphovascular invasion or discontinuous foci of tumor cells
[51]. Risk factors for metachronous recurrence or prognosis
are the subject of future investigations. Finally, all patients
examined in this study were Japanese. Some biological differ-
ences might be seen between Japan and the Western World.
Further multicenter trials in the Eastern and Western World
would be necessary before the B1000 μm borderB is excluded
for risk stratification.
In conclusion, the present study showed several problems
of measuring SID and demonstrated that SID is not an impor-
tant risk factor for LNM. If the surface layer was used as the
baseline, all cases would be ≥1000 μm. SID is associated with
lesion morphology, and it can sometimes become shorter in
progression of the lesions. Some lesions with SID <1000 μm
had LNM, whereas SID ≥1000 μm was not a significant risk
factor for LNM. Moreover, among lesions with SID
≥1000 μm but no pathological factors associated with LNM,
none had LNM. SID should be reconsidered as a risk factor for
LNM, or an indicator for additional surgery.We need to devise
more accurate methods to assess lesions at high risk for LNM
without measuring SID.
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